SHUKRA PHARMACEUTICALS
Back to Balance Sheet
|
SHUKRA PHARMACEUTICALS Last 5 Year Contingent Liabilities History
[Standalone]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Contingent Liabilities | ₹1.40 Cr | ₹1.40 Cr | - | ₹1.40 Cr | - |
What is the latest Contingent Liabilities ratio of SHUKRA PHARMACEUTICALS ?
| Year | Contingent Liabilities |
|---|---|
| Mar2025 | ₹1.40 Cr |
| Mar2024 | ₹1.40 Cr |
| Mar2023 | - |
| Mar2022 | ₹1.40 Cr |
| Mar2021 | - |
How is Contingent Liabilities of SHUKRA PHARMACEUTICALS Trending?
| Years | Contingent Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹1.40 Cr | 0.00 | |
| Mar2024 | ₹1.40 Cr | 0 | |
| Mar2023 | - | -100.00 | |
| Mar2022 | ₹1.40 Cr | 0 | |
| Mar2021 | - | - | |
Compare Contingent Liabilities of peers of SHUKRA PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SHUKRA PHARMACEUTICALS | ₹1,755.1 Cr | 7.1% | -6% | 97.8% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹428,185.0 Cr | 3.5% | 12.3% | 5.6% | Stock Analytics | |
| DIVIS LABORATORIES | ₹171,766.0 Cr | 2.8% | 7.2% | 7.1% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹148,923.0 Cr | 3.8% | 12.1% | 42.8% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹110,081.0 Cr | 3% | 9.1% | 11.6% | Stock Analytics | |
| CIPLA | ₹109,680.0 Cr | 1.2% | 2.8% | -9.1% | Stock Analytics | |
SHUKRA PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SHUKRA PHARMACEUTICALS | 7.1% |
-6% |
97.8% |
| SENSEX | -0.3% |
-0.1% |
8.3% |
You may also like the below Video Courses